The Role of Inflammatory Parameters and Antibody Seroconversion on COVID-19 Outcomes in Patients with Central Obesity
Abstract
Keywords
References
Liu Y, Douglas PS, Lip GYH, et al. Relationship between obesity severity, metabolic status and cardiovascular disease in obese adults. Eur J Clin Invest. 2023;53(3):e13912.
Tadayon Najafabadi B, Rayner DG, et al. Obesity as an independent risk factor for COVID-19 severity and mortality. Cochrane Database Syst Rev. 2023;5(5):CD015201.
Re F, Oguntade AS, Bohrmann B, et al. Associations of general and central adiposity with hypertension and cardiovascular disease among South Asian populations: a systematic review and meta-analysis. BMJ Open. 2023;13(12):e074050.
Goh VHH, Hart WG. Excess fat in the abdomen but not general obesity is associated with poorer metabolic and cardiovascular health in premenopausal and postmenopausal Asian women. Maturitas. 2018;107:33-8.
Földi M, Farkas N, Kiss S, et al. Visceral adiposity elevates the risk of critical condition in COVID‐19: A systematic review and meta‐analysis. Obesity. 2021;29(3):521-8.
Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007;56(4):1010-3.
Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6. Diabetes Res Clin Pract. 2005;69(1):29-35.
Schäffler A. [Role of metaflammation as a systemic manifestation of metabolic diseases]. Inn Med (Heidelb). 2023;64(4):313-22.
Frasca D, Blomberg BB. Adipose Tissue Inflammation Induces B Cell Inflammation and Decreases B Cell Function in Aging. Fronti Immunol. 2017;8(1003).
Frasca D, Reidy L, Cray C, et al. Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients. PLoS One. 2021;16(3):e0245424.
Ren L, Zhang L, Chang D, et al. The kinetics of humoral response and its relationship with the disease severity in COVID-19. Commun Biol. 2020;3(1):1-7.
Zohar T, Loos C, Fischinger S, et al. Compromised humoral functional evolution tracks with SARS-CoV-2 mortality. Cell. 2020;183(6):1508-19. e12.
Post N, Eddy D, Huntley C, et al. Antibody response to SARS-CoV-2 infection in humans: a systematic review. PloS one. 2020;15(12):e0244126.
Tahapary D. COVID-19, Aging, and Cardiometabolic Risk Factors Study (CARAMEL) 2018 [cited 2024 31 May]. Available from: https://clinicaltrials.gov/ct2/show/NCT04802044)
World Health Organization. Regional Office for the Western P. The Asia-Pacific perspective : redefining obesity and its treatment: Sydney : Health Communications Australia; 2000
Russo S, Kwiatkowski M, Govorukhina N, Bischoff R, Melgert BN. Meta-inflammation and metabolic reprogramming of macrophages in diabetes and obesity: the importance of metabolites. Front Immunol. 2021;12:746151.
Wacharasint P, Boyd JH, Russell JA, Walley KR. One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response. Crit Care. 2013;17(3):R122.
Domingos IF, Pereira-Martins DA, Sobreira MJVC, et al. High levels of proinflammatory cytokines IL-6 and IL-8 are associated with a poor clinical outcome in sickle cell anemia. Ann Hematol. 2020;99(5):947-53.
Korakas E, Ikonomidis I, Kousathana F, et al. Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes. Am J Physiol Endocrinol Metab. 2020;319(1):E105-E9.
Herold T, Jurinovic V, Arnreich C, et al. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol. 2020;146(1):128-36.e4.
Shekhawat J, Gauba K, Gupta S, et al. Interleukin-6 perpetrator of the COVID-19 cytokine storm. Indian J Clin Biochem. 2021;36(4):440-50.
Meduri GU, Headley S, Kohler G, et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: Plasma IL-1β and IL-6 levels are consistent and efficient predictors of outcome over time. Chest. 1995;107(4):1062-73.
Sheu K, Luecke S, Hoffmann A. Stimulus-specificity in the responses of immune sentinel cells. Curr Opin Syst Biol. 2019;18:53-61.
Yeung YT, Aziz F, Guerrero-Castilla A, Arguelles S. Signaling pathways in inflammation and anti-inflammatory therapies. Curr Pharm Des. 2018;24(14):1449-84.
Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.
Frasca D, Blomberg BB. The impact of obesity and metabolic syndrome on vaccination success. Interdiscip Top Gerontol Geriatr. 2020;43:86-97.
Singh S, Anshita D, Ravichandiran V. MCP-1: Function, regulation, and involvement in disease. Int Immunopharmacol. 2021;101(Pt B):107598.
Zhao Y, Qin L, Zhang P, et al. Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease. JCI Insight. 2020;5(13).
Motwani MP, Newson J, Kwong S, et al. Prolonged immune alteration following resolution of acute inflammation in humans. PLOS ONE. 2017;12(10):e0186964.
Song J, Deng T. The adipocyte and adaptive immunity. Front Immunol. 2020;11.
Tahtinen S, Tong A-J, Himmels P, et al. IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines. Nat Immunol. 2022;23(4):532-42.
Takita M, Yoshida T, Tsuchida T, et al. Low SARS-CoV-2 antibody titers may be associated with poor clinical outcomes for patients with severe COVID-19. Sci Rep. 2022;12(1):9147.
Lynch KL, Whitman JD, Lacanienta NP, et al. Magnitude and kinetics of anti–severe acute respiratory syndrome coronavirus 2 antibody responses and their relationship to disease severity. Clin Infect Dis. 2021;72(2):301-8.
Refbacks
- There are currently no refbacks.